[Double-blind clinical trial of a new coronary-active drug, MD 6753].
D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy*; D001794:Blood Pressure; D002934:Cinnamates / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003326:Coronary Circulation; D003327:Coronary Disease / Q000188:drug therapy*; D004338:Drug Combinations; D004562:Electrocardiography; D005080:Exercise Test; D005260:Female; D006321:Heart / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use*; D010919:Placebos; D014665:Vasodilator Agents / Q000627:therapeutic use*
D002934:Cinnamates; D004338:Drug Combinations; D010879:Piperazines; D010919:Placebos; D014665:Vasodilator Agents; D005996:Nitroglycerin
Sperimentazione clinica in doppio cieco di un nuovo coronaroattivo, 6753 M.D